Cargando…

CAR T Cell Locomotion in Solid Tumor Microenvironment

The promising outcomes of chimeric antigen receptor (CAR) T cell therapy in hematologic malignancies potentiates its capability in the fight against many cancers. Nevertheless, this immunotherapy modality needs significant improvements for the treatment of solid tumors. Researchers have incrementall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Duy T., Ogando-Rivas, Elizabeth, Liu, Ruixuan, Wang, Theodore, Rubin, Jacob, Jin, Linchun, Tao, Haipeng, Sawyer, William W., Mendez-Gomez, Hector R., Cascio, Matthew, Mitchell, Duane A., Huang, Jianping, Sawyer, W. Gregory, Sayour, Elias J., Castillo, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221866/ https://www.ncbi.nlm.nih.gov/pubmed/35741103 http://dx.doi.org/10.3390/cells11121974

Ejemplares similares

Three-Dimensional Bioconjugated Liquid-Like Solid (LLS) Enhance Characterization of Solid Tumor - Chimeric Antigen Receptor T cell interactions
por: Nguyen, Duy T., et al.
Publicado: (2023)

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes
por: Sayour, Elias J., et al.
Publicado: (2018)

COVD-02. ADAPTING RNA-NANOPARTICLE VACCINES FROM GLIOBLASTOMA TO SARS-COV-2
por: Mendez-Gomez, Hector, et al.
Publicado: (2020)

Optimizing T Cell-Based Therapy for Glioblastoma
por: Karachi, Aida, et al.
Publicado: (2021)

CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
por: Jin, Linchun, et al.
Publicado: (2019)

Evolution and Revolution of Imaging Technologies in Neurosurgery
por: OGANDO-RIVAS, Elizabeth, et al.
Publicado: (2022)

Immunotherapy for Pediatric Brain Tumors
por: Sayour, Elias J., et al.
Publicado: (2017)

Manipulation of Innate and Adaptive Immunity through Cancer Vaccines
por: Sayour, Elias J., et al.
Publicado: (2017)

The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
por: Mu, Luyan, et al.
Publicado: (2018)

IMMU-13. CUSTOMIZABLE MULTI-LAMELLAR RNA-NANOPARTICLES FOR PEDIATRIC GLIOMA
por: Mendez-Gomez, Hector, et al.
Publicado: (2021)

Emerging trends in immunotherapy for pediatric sarcomas
por: Dyson, Kyle A., et al.
Publicado: (2019)

Translational nanoparticle engineering for cancer vaccines
por: Grippin, Adam J., et al.
Publicado: (2017)

2422: Magnetic nanoparticles facilitate tracking of dendritic cells for treatment of malignant brain tumors
por: Grippin, Adam, et al.
Publicado: (2018)

IMMU-16. IDENTIFICATION OF TUMOR REJECTION ANTIGENS FOR PRECISION ADOPTIVE CELLULAR THERAPY FOR PEDIATRIC GLIOMAS
por: Trivedi, Vrunda, et al.
Publicado: (2023)

Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics
por: Sayour, Elias J, et al.
Publicado: (2015)

Contemporary RNA Therapeutics for Glioblastoma
por: Melnick, Kaitlyn, et al.
Publicado: (2021)

IMMU-06. SYSTEMIC MRNA VACCINES RESET IMMUNOGENICITY AGAINST DIFFUSE MIDLINE GLIOMA
por: McGuiness, James, et al.
Publicado: (2023)

Direct imaging of RNA loaded lipid-nanoparticles’ self assembly and cellular expression for cancer immunotherapy and RNA-based vaccines
por: Ashbrook, Jewel, et al.
Publicado: (2022)

CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression
por: Mu, Luyan, et al.
Publicado: (2017)

Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
por: Lindo, Lorenzo, et al.
Publicado: (2021)

Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles
por: Sayour, Elias J., et al.
Publicado: (2016)

2173 RNA-nanoparticles to enhance and track dendritic cell migration
por: Grippin, Adam J., et al.
Publicado: (2018)

Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer
por: Henze, Janina, et al.
Publicado: (2020)

CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
por: Kankeu Fonkoua, Lionel A., et al.
Publicado: (2022)

S188: CAR-T CELLS SHAPE THE IMMUNOLOGICAL POTENTIAL OF THE TUMOR MICROENVIRONMENT
por: Frede, Julia, et al.
Publicado: (2023)

Adaptive locomotion of artificial microswimmers
por: Huang, H.-W., et al.
Publicado: (2019)

Association of Suppressive Myeloid Cell Enrichment with Aggressive Oropharynx Squamous Cell Carcinoma
por: Yang, Changlin, et al.
Publicado: (2023)

Primate locomotion
Publicado: (1974)

Catechism of the locomotive
por: Forney, Matthias N.
Publicado: (1950)

Actin in locomotion
por: Bonetta, Laura
Publicado: (2005)

Animal Locomotion
por: Taylor, Graham K, et al.
Publicado: (2010)

The perils of locomotion
por: Van Epps, Heather L.
Publicado: (2006)

Torsional locomotion
por: Bigoni, D., et al.
Publicado: (2014)

London Locomotion
Publicado: (1903)

Man and the Locomotive
Publicado: (1874)

Human Locomotion
Publicado: (1874)

City Locomotion
Publicado: (1873)

Fireless Locomotives
Publicado: (1881)

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
por: Yeku, Oladapo O., et al.
Publicado: (2017)

CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fkddnre02v0fh0s75hq6tagtaj